Rx Green Technologies

About Rx Green Technologies

Rx Green Technologies, founded by Todd Brady in 2011, operates as a specialized provider of agricultural inputs and services tailored for the commercial cannabis cultivation market. The company was established just before the wave of recreational cannabis legalization in Colorado, based on the insight that scaling cultivators would require scientifically developed, ROI-driven solutions and robust technical support. This foresight led to the creation of the industry's first direct, technical sales force in 2015.

The company's business model is built on a direct-to-cultivator sales and service approach, shipping from its vertically integrated manufacturing sites directly to commercial growers. This strategy ensures a predictable supply chain, competitive pricing, and a close support relationship with clients, covering everything from logistics to technical assistance throughout the crop cycle. Revenue is generated through the sale of its comprehensive product line. Headquartered in New Hampshire with a presence in Denver, the company has expanded its operations, including moving to a larger facility in Londonderry, NH, to establish a second manufacturing plant for its East Coast customers.

Rx Green Technologies offers a wide array of consumable products for cannabis cultivation, including nutrients, substrates, pest management solutions, growing mediums, and cloning aids. A cornerstone of its value proposition is a dedicated research and development platform within a licensed cannabis cultivation facility, allowing for rigorous product testing on live cannabis plants. This scientific backing enables the company to formulate products like their dye-free Liquid Fertilizers 2.0 line, which includes added fulvic acid and magnesium to enhance plant growth and quality while preventing deficiencies. All products are also tested by third-party labs to ensure quality and safety. The company has secured $20.7M in total funding over four rounds, with a significant Series B round of $9.75M in November 2021 led by Intrinsic Capital Partners to fuel expansion and R&D.